PHARMING GROUP NVPHARMING GROUP NVPHARMING GROUP NV

PHARMING GROUP NV

No trades
See on Supercharts

PHGN fundamentals

PHARMING GROUP NV financial statements, including revenue, expenses, profit, and loss

The total revenue of PHGN for the last quarter is 51.21 M EUR, and it's 32.17% lower compared to the previous quarter. The net income of Q1 24 is -11.47 M EUR.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth